SCHEMBL22493943

SCHEMBL22493943

N[C@H]1C[C@@H](C(=O)O)C(F)(F)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 1/20 0.38
CHRNB2 P17787 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA4 P43681 1/20 0.36
CHRNB3 Q05901 1/20 0.36
CHRNA6 Q15825 1/20 0.36
GABRR1 P24046 1/20 0.36
GRM4 Q14833 7/20 0.35
CYP1A2 P05177 3/20 0.35
CYP2C19 P33261 3/20 0.35
GRM8 O00222 3/20 0.35
ALDH1A1 P00352 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
GRM6 O15303 2/20 0.35
ALOX15 P16050 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22500876 1.00 SLC6A4 (0.38) SLC6A4CHRNB2CHRNA3CHRNA4CHRNB3
Hydrochloric Acid SCHEMBL22493932 0.98 SLC6A4 (0.37) SLC6A4CHRNB2CHRNA3CHRNA4CHRNB3
SCHEMBL22493906 0.79 GABRR1 (0.33) SLC6A4GABRR1
SCHEMBL12473695 0.78
SCHEMBL301120 0.78
SCHEMBL1173556 0.78
Hydrochloric Acid SCHEMBL11821301 0.76
Bromide SCHEMBL11824101 0.76
SCHEMBL22519005 0.74 CHRNB2 (0.36) SLC6A4CHRNB2CHRNA3CHRNA4CHRNB3
Hydrochloric Acid SCHEMBL31072095 0.67 SLC6A4 (0.40) SLC6A4GABRR1GRM4CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11078153-B2 2-difluoro substituted 4-aminocyclopentanecarboxylic acids as inhibitors of gamma-aminobutyric acid aminotransferase and human ornithine aminotransferase NORTHWESTERN UNIVERSITY (US) 2021-08-03 US disclosed
US-11078153-B2 2-difluoro substituted 4-aminocyclopentanecarboxylic acids as inhibitors of gamma-aminobutyric acid aminotransferase and human ornithine aminotransferase NORTHWESTERN UNIVERSITY (US) 2021-08-03 US disclosed
US-20200317606-A1 2-DIFLUORO SUBSTITUTED 4-AMINOCYCLOPENTANECARBOXYLIC ACIDS AS INHIBITORS OF GAMMA-AMINOBUTYRIC ACID AMINOTRANSFERASE AND HUMAN ORNITHINE AMINOTRANSFERASE NORTHWESTERN UNIVERSITY (US) 2020-10-08 US disclosed
WO-2020206234-A1 2-DIFLUORO SUBSTITUTED 4-AMINOCYCLOPENTANECARBOXYLIC ACIDS AS INHIBITORS OF GAMMA-AMINOBUTYRIC ACID AMINOTRANSFERASE AND HUMAN ORNITHINE AMINOTRANSFERASE NORTHWESTERN UNIVERSITY (US) 2020-10-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11078153-B2 2-difluoro substituted 4-aminocyclopentanecarboxylic acids as inhibitors of gamma-aminobutyric acid aminotransferase and human ornithine aminotransferase OAT, OTC, SLC6A13 SLC6A4 226/4885CHRNB2 1529/4885CHRNA3 1881/4885
US-20200317606-A1 2-DIFLUORO SUBSTITUTED 4-AMINOCYCLOPENTANECARBOXYLIC ACIDS AS INHIBITORS OF GAMMA-AMINOBUTYRIC ACID AMINOTRANSFERASE AND HUMAN ORNITHINE AMINOTRANSFERASE OAT, OTC, SLC6A13 SLC6A4 226/4885CHRNB2 1529/4885CHRNA3 1881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.